ArticleOncotarget2016

Cdc6 contributes to cisplatin-resistance by activation of ATR-Chk1 pathway in bladder cancer cells.

Sansan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.